{"id":231817,"date":"2022-09-06T15:25:00","date_gmt":"2022-09-06T15:25:00","guid":{"rendered":"https:\/\/haftavasool.com\/haftavasool\/?p=231817"},"modified":"2022-09-06T15:25:00","modified_gmt":"2022-09-06T15:25:00","slug":"bharat-biotechs-nasal-vaccine-against-covid-19-cleared-for-use","status":"publish","type":"post","link":"https:\/\/haftavasool.com\/haftavasool\/blog\/2022\/09\/06\/bharat-biotechs-nasal-vaccine-against-covid-19-cleared-for-use\/","title":{"rendered":"Bharat Biotech&#8217;s Nasal Vaccine Against Covid-19 Cleared For Use"},"content":{"rendered":"<p> [ad_1]<br \/>\n<\/p>\n<div itemprop=\"articleBody\" id=\"ins_storybody\"><!-- \n\n<div itemprop=\"articleBody\" class=\"sp-cn ins_storybody\" id=\"ins_storybody\">--><\/p>\n<div class=\"ins_instory_dv\">\n<div class=\"ins_instory_dv_cont\"><img decoding=\"async\" title=\"Bharat Biotech's Nasal Vaccine Against Covid-19 Cleared For Use\" alt=\"Bharat Biotech's Nasal Vaccine Against Covid-19 Cleared For Use\" id=\"story_image_main\" src=\"https:\/\/c.ndtvimg.com\/2022-04\/iptdjlsg_coronavirus-india-pti-pic_650x400_20_April_22.jpg\"\/><\/div>\n<\/div>\n<p><b class=\"place_cont\">New Delhi: <\/b><\/p>\n<p>A nasal vaccine against Covid-19, developed by Bharat Biotech, has been approved by the drug controller, for &#8220;restricted use&#8221; among adults &#8220;in emergency situation&#8221;, said\u00a0Union Health Minister Dr Mansukh Mandaviya.<\/p>\n<blockquote class=\"twitter-tweet\">\n<p dir=\"ltr\" lang=\"en\">Big Boost to India&#8217;s Fight Against COVID-19!<\/p>\n<p>Bharat Biotech&#8217;s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by <a href=\"https:\/\/twitter.com\/CDSCO_INDIA_INF?ref_src=twsrc%5Etfw\">@CDSCO_INDIA_INF<\/a> for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation.<\/p>\n<p>\u2014 Dr Mansukh Mandaviya (@mansukhmandviya) <a href=\"https:\/\/twitter.com\/mansukhmandviya\/status\/1567080427575459840?ref_src=twsrc%5Etfw\">September 6, 2022<\/a><\/p><\/blockquote>\n<p>&#8220;India has harnessed its science, research and development, and human resources&#8230; under PM Narendra Modi&#8217;s leadership,&#8221; the minister said.<\/p>\n<p>In February, in what was the country&#8217;s first such anti-Covid drug, Mumbai-based Glenmark launched a nasal spray (branded FabiSpray) in partnership with SaNOtize, for treatment of adult patients.<\/p>\n<p>The company got manufacturing and marketing approvals from the Drugs Controller General of India for its Nitric Oxide Nasal Spray as part of an accelerated approval process.\u00a0&#8220;Phase 3 trial in India met the key endpoints and demonstrated reduction of viral load of 94 per cent in 24 hours and 99 per cent in 48 hours,&#8221; the official statement said.<\/p>\n<p>As for the pandemic status today, India saw a single-day rise of 4,417 coronavirus infections, which is the lowest in three months, as per government data updated at 8 am on Tuesday.\u00a0<\/p>\n<p>Active Covid cases have declined to 52,336, while there were 23 fatalities reported.<\/p>\n<p>The active cases now comprise 0.12 per cent of the total infections while the recovery rate has increased to 98.69 per cent, the Health Ministry said.<\/p>\n<p>Vaccine development is seeing a boost too, across the world. UK health authorities on Saturday approved a second &#8220;bivalent&#8221; vaccine to be used as a booster to target both the Omicron and original strains of the virus.<\/p>\n<\/div>\n<p><script async src=\"\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><br \/>\n<br \/>[ad_2]<br \/>\n<br \/><a href=\"https:\/\/www.ndtv.com\/india-news\/coronavirus-bharat-biotechs-nasal-vaccine-against-covid-19-cleared-for-use-3320179\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[ad_1] New Delhi: A nasal vaccine against Covid-19, developed by Bharat Biotech, has been approved by the drug controller, for &#8220;restricted use&#8221; among adults &#8220;in emergency situation&#8221;, said\u00a0Union Health Minister Dr Mansukh Mandaviya. Big Boost to India&#8217;s Fight Against COVID-19! Bharat Biotech&#8217;s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":231818,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[10512,1288,171659],"_links":{"self":[{"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/posts\/231817"}],"collection":[{"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/comments?post=231817"}],"version-history":[{"count":0,"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/posts\/231817\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/media\/231818"}],"wp:attachment":[{"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/media?parent=231817"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/categories?post=231817"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/tags?post=231817"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}